Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ IL13RA1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA550989
Description
IL13RA1 Polyclonal Antibody detects endogenous levels of IL13RA1 protein.
The protein encoded by this gene is a subunit of the interleukin 13 receptor. This subunit forms a receptor complex with IL4 receptor alpha, a subunit shared by IL13 and IL4 receptors. This subunit serves as a primary IL13-binding subunit of the IL13 receptor, and may also be a component of IL4 receptors. This protein has been shown to bind tyrosine kinase TYK2, and thus may mediate the signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4.
Specifications
IL13RA1 | |
Polyclonal | |
Unconjugated | |
IL13RA1 | |
AI882074; Cancer/testis antigen 19; CD antigen CD213a1; CD213a1; CD213a1 antigen; CT19; IL13 receptor alpha-1 chain; IL-13 receptor subunit alpha-1; IL13R; IL-13R subunit alpha-1; IL-13r[a]; IL13RA; IL-13Ra; IL13RA1; IL-13RA1; IL-13R-alpha-1; interleukin 13 receptor subunit alpha 1; interleukin 13 receptor, alpha 1; interleukin 13 receptor, alpha 1-like; interleukin-13 receptor subunit alpha-1; Interleukin-13-binding protein; LOC100360218; Novel cytokine receptor 4; NR4 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
100360218, 16164, 252963, 3597 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
ELISA, Immunohistochemistry, Western Blot, Immunocytochemistry | |
1 mg/mL | |
PBS with 0.5% BSA, 50% glycerol and 0.02% sodium azide; pH 7.4 | |
O09030, P78552 | |
IL13RA1, LOC100360218 | |
Synthesized peptide derived from human IL-13Rα1 around the non-phosphorylation site of Y405. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction